C. Miller

发表

Evaluation of CDC’s Hemophilia Surveillance Program — Universal Data Collection (1998–2011) and Community Counts (2011–2019), United States

L. Schieve, W. Hooper, V. Byams, 2020, Morbidity and mortality weekly report. Surveillance summaries.

A Public Health Approach to the Prevention of Inhibitors in Hemophilia

Meredith A Oakley, C. Miller, J. Soucie, 2014, American journal of preventive medicine.

F8 gene mutation type and inhibitor development in patients with severe hemophilia A: systematic review and meta-analysis.

M. Margaglione, S. Cessie, S. le Cessie, 2012, Blood.

Platelet Function Analyzer

C. Miller, 2019, Transfusion Medicine and Hemostasis.

Platelet Function Analyzer

C. Miller, 2013 .

Global Tests of Primary Hemostasis

C. Miller, 2009 .

Genetic counselling in haemophilia by discriminant analysis 1975-1980*

C. Miller, H. Reisner, E. S. Barrow, 1982, Journal of medical genetics.

Gender, race and diet affect platelet function tests in normal subjects, contributing to a high rate of abnormal results

C. Miller, S. Stein, A. S. Rice, 2014, British journal of haematology.

Multisite management study of menorrhagia with abnormal laboratory haemostasis: a prospective crossover study of intranasal desmopressin and oral tranexamic acid

N. Dowling, J. Heit, B. Evatt, 2009, British journal of haematology.

Complications associated with carrier status among people with blood disorders: a commentary.

W. Hooper, N. Key, C. Miller, 2010, American journal of preventive medicine.

Measurement of von Willebrand factor activity: relative effects of ABO blood type and race

B. Evatt, C. Miller, E. Håff, 2003, Journal of thrombosis and haemostasis : JTH.

Platelet functional defects in women with unexplained menorrhagia

R. Schwartz, G. Bachmann, B. Evatt, 2003, Journal of thrombosis and haemostasis : JTH.

National surveillance for hemophilia inhibitors in the United States: Summary report of an expert meeting

D. Aschman, B. Konkle, P. Monahan, 2014, American journal of hematology.

Genetic causes of haemophilia in women and girls

C. Miller, C. Bean, 2020, Haemophilia : the official journal of the World Federation of Hemophilia.

Laboratory Diagnosis of Acquired von Willebrand’s Syndrome

C. Miller, 2019, Transfusion Medicine and Hemostasis.

Platelet Aggregation Studies

C. Miller, 2019, Transfusion Medicine and Hemostasis.

Evaluation of anti‐factor VIII antibody levels in patients with haemophilia A receiving immune tolerance induction therapy or bypassing agents

C. Miller, B. Boylan, G. Niemeyer, 2020, Haemophilia : the official journal of the World Federation of Hemophilia.

Antiplatelet Therapy Monitoring

C. Miller, M. Roshal, 2019, Transfusion Medicine and Hemostasis.

The CDC Hemophilia A Mutation Project (CHAMP) Mutation List: A New Online Resource

C. Miller, F. Kelly, A. Payne, 2013, Human mutation.

High factor VIII, von Willebrand factor, and fibrinogen levels and risk of venous thromboembolism in blacks and whites.

H. Austin, W. Hooper, C. Miller, 2014, Ethnicity & disease.

The relationship of the factor V Leiden mutation and pregnancy outcomes for mother and fetus.

B. Sibai, S. Gabbe, E. Thom, 2006, Obstetrics and gynecology.

The Clinical Genetics of Hemophilia B (Factor IX Deficiency)

C. Miller, 2021, The application of clinical genetics.

TACG_A_288256 445..454

C. Miller, 2021 .

Limit of detection and threshold for positivity of the Centers for Disease Control and Prevention assay for factor VIII inhibitors

A. Shapiro, C. Miller, B. Wicklund, 2017, Journal of thrombosis and haemostasis : JTH.

Laboratory Tests for the Diagnosis of Thrombotic Disorders

C. Miller, 2006, Clinical obstetrics and gynecology.

Population differences in von Willebrand factor levels affect the diagnosis of von Willebrand disease in African‐American women

B. Evatt, W. Hooper, C. Miller, 2001, American journal of hematology.

Changes in von Willebrand Factor and Factor VIII Levels during the Menstrual Cycle

B. Evatt, C. Miller, A. Dilley, 2002, Thrombosis and Haemostasis.

Bleeding Disorders in Women and Girls: State of the Science and CDC Collaborative Programs.

L. Schieve, V. Byams, C. Miller, 2022, Journal of women's health.

Mutation analysis of a cohort of US patients with hemophilia B

W. Hooper, C. Miller, A. Payne, 2014, American journal of hematology.

Comparison of clot‐based, chromogenic and fluorescence assays for measurement of factor VIII inhibitors in the US Hemophilia Inhibitor Research Study

A. Shapiro, C. Miller, J. Soucie, 2013, Journal of thrombosis and haemostasis : JTH.

In non‐severe hemophilia A the risk of inhibitor after intensive factor treatment is greater in older patients: a case–control study

C. Kempton, N. Key, C. Miller, 2010, Journal of thrombosis and haemostasis : JTH.

Females with FVIII and FIX deficiency have reduced joint range of motion

M. DeBaun, W. Hooper, C. Miller, 2014, American journal of hematology.

Characteristics of hemophilia patients with factor VIII inhibitors detected by prospective screening

C. Leissinger, J. Gill, C. Miller, 2015, American journal of hematology.

In vitro factor VIII recovery during the delivery of ultra‐pure factor VIII concentrate by continuous infusion

C. Miller, D. DiMichele, Martin E. Lasak, 1996, American journal of hematology.

von Willebrand Disease and Other Inherited Bleeding Disorders in Women With Diagnosed Menorrhagia

H. Austin, B. Evatt, C. Miller, 2001, Obstetrics and gynecology.

Occurrence rates of von Willebrand disease among people receiving care in specialized treatment centres in the United States

P. Kouides, V. Byams, C. Miller, 2021, Haemophilia : the official journal of the World Federation of Hemophilia.

Occurrence rates of haemophilia among males in the United States based on surveillance conducted in specialized haemophilia treatment centres

T. Buckner, Brandi Dupervil, C. Miller, 2020, Haemophilia : the official journal of the World Federation of Hemophilia.

Impact of inhibitors on hemophilia a mortality in the United States

C. Miller, J. Soucie, C. Walsh, 2015, American journal of hematology.

Diagnosis of von Willebrand disease type 2N: A simplified method for measurement of factor VIII binding to von Willebrand factor

C. Miller, D. Green, Leslie Kelley, 1998, American journal of hematology.

Women and girls with haemophilia receiving care at specialized haemophilia treatment centres in the United States

T. Buckner, V. Byams, C. Miller, 2021, Haemophilia : the official journal of the World Federation of Hemophilia.

Improving the performance of factor VIII inhibitor tests in hemophilia A.

C. Miller, 2015, Thrombosis research.

Survey of the anti–factor IX immunoglobulin profiles in patients with hemophilia B using a fluorescence‐based immunoassay

C. Kempton, A. Neff, C. Miller, 2016, Journal of thrombosis and haemostasis : JTH.

A study of prospective surveillance for inhibitors among persons with haemophilia in the United States

C. Kempton, A. Neff, D. Brettler, 2014, Haemophilia : the official journal of the World Federation of Hemophilia.

The CDC Hemophilia B mutation project mutation list: a new online resource

C. Miller, A. Payne, W. Craig Hooper, 2013, Molecular genetics & genomic medicine.

Chapter 128 – Specific Factor Inhibitor Testing

C. Miller, 2013 .

Specific Factor Inhibitor Testing

C. Miller, 2009 .

Monitoring of von Willebrand factor inhibitors in patients with type 3 von Willebrand disease using a quantitative assay

C. Miller, 2021, Haemophilia : the official journal of the World Federation of Hemophilia.

Age and the Prevalence of Bleeding Disorders in Women With Menorrhagia

Ambarina S. Faiz, N. Dowling, G. Bachmann, 2005, Obstetrics and gynecology.

Evaluation of a screening tool for bleeding disorders in a US multisite cohort of women with menorrhagia.

Ambarina S. Faiz, J. Heit, P. Kouides, 2011, American journal of obstetrics and gynecology.

Evaluation of Two Automated Methods for Measurement of the Ristocetin Cofactor Activity of von Willebrand Factor

C. Miller, S. J. Platt, D. Kaczor, 2002, Thrombosis and Haemostasis.

Pancreatitis in HIV-Positive Hemophiliacs

C. Miller, M. Kletzel, J. Elser, 1991 .

Laboratory response to intranasal desmopressin in women with menorrhagia and platelet dysfunction

Ambarina S. Faiz, P. Saidi, C. Miller, 2008, Haemophilia : the official journal of the World Federation of Hemophilia.

Screening women with menorrhagia for underlying bleeding disorders: the utility of the platelet function analyser and bleeding time

Ambarina S. Faiz, N. Dowling, G. Bachmann, 2005, Haemophilia : the official journal of the World Federation of Hemophilia.

Factor V Leiden and Factor V R2 Allele: High-throughput Analysis and Association with Venous Thromboembolism

W. Hooper, B. Evatt, C. Miller, 2001, Thrombosis and Haemostasis.

Game, set, match for factor VIII mismatch?

C. Miller, 2015, Blood.

Sensory evaluations of a novel iron and zinc-enriched powder for the treatment and prevention of iron deficiency in women of reproductive age.

C. Miller, K. Connor, H. Sheyholislami, 2022, medRxiv.

The Relationship of the Factor V Leiden Mutation and Pregnancy Outcomes for Mother and Fetus

B. Sibai, S. Gabbe, E. Thom, 2005 .

Evaluation of von Willebrand factor phenotypes and genotypes in Hemophilia A patients with and without identified F8 mutations

C. Miller, C. Bean, H. Yaish, 2015, Journal of thrombosis and haemostasis : JTH.

Reagent substitution in the chromogenic Bethesda assay for factor VIII inhibitors

C. Miller, C. Bean, A. Payne, 2019, Haemophilia : the official journal of the World Federation of Hemophilia.

Validation of Nijmegen–Bethesda assay modifications to allow inhibitor measurement during replacement therapy and facilitate inhibitor surveillance

C. Miller, J. Soucie, F. Kelly, 2012, Journal of thrombosis and haemostasis : JTH.

Cluster of inhibitors among adult inpatients with haemophilia in a single institution

T. Buckner, W. Hooper, N. Key, 2015, Haemophilia : the official journal of the World Federation of Hemophilia.

Utility of multiplex ligation‐dependent probe amplification (MLPA) for hemophilia mutation screening

W. Hooper, C. Miller, C. Bean, 2012, Journal of thrombosis and haemostasis : JTH.

Elevated factorVII as a risk factor for recurrent fetal loss Relationship to factorVII gene polymorphisms

B. Evatt, C. Miller, A. Dilley, 2017 .

The spectrum of haemostatic characteristics of women with unexplained menorrhagia

N. Dowling, J. Heit, P. Kouides, 2011, Haemophilia : the official journal of the World Federation of Hemophilia.

Elevated factor VII as a risk factor for recurrent fetal loss

B. Evatt, C. Miller, A. Dilley, 2005, Thrombosis and Haemostasis.

Characterization of the anti‐factor VIII immunoglobulin profile in patients with hemophilia A by use of a fluorescence‐based immunoassay

D. Brettler, C. Miller, M. Tarantino, 2015, Journal of thrombosis and haemostasis : JTH.

Phenotypic and genotypic differences in factor XII between African Americans and Caucasians

C. Miller, C. Hooper, 2007, Journal of thrombosis and haemostasis : JTH.

F8 and F9 mutations in US haemophilia patients: correlation with history of inhibitor and race/ethnicity

W. Hooper, C. Miller, J. Soucie, 2012, Haemophilia : the official journal of the World Federation of Hemophilia.

A second BamHI DNA polymorphism and haplotype association in the factor IX gene.

A. Dispenzieri, C. Miller, L. Aledort, 1988, Blood.

Stability of specimens for use in the Centers for Disease Control and Prevention assays for factor VIII and IX inhibitors

C. Miller, C. Bean, B. Boylan, 2022, Research and Practice in Thrombosis and Haemostasis.

The chromogenic Bethesda assay and the Nijmegen‐Bethesda assay for factor VIII inhibitors in hemophilia A patients: Are they equivalent?

C. Miller, B. Boylan, 2021, Journal of thrombosis and haemostasis : JTH.

Validation of the chromogenic Bethesda assay for factor VIII inhibitors in hemophilia a patients receiving Emicizumab

C. Miller, C. Bean, B. Boylan, 2020, International Journal of Laboratory Hematology.

Evaluation of pre‐analytic heat treatment protocol used in the CDC Nijmegen‐Bethesda assay for heat inactivation of extended half‐life haemophilia treatment products

C. Miller, C. Bean, D. Ellingsen, 2019, Haemophilia : the official journal of the World Federation of Hemophilia.

IgG subclass identification of inhibitors to factor IX in haemophilia B patients

C. Miller, K. Örstavik, 1988, British journal of haematology.

Laboratory Diagnosis of Platelet Function Defects

C. Miller, 2013 .

Mutations in the factor V, prothrombin and MTHFR genes are not risk factors for recurrent fetal loss

H. Austin, W. Hooper, B. Evatt, 2002, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

Laboratory response to intranasal desmopressin in women with menorrhagia and platelet dysfunction

Ambarina S. Faiz, P. Saidi, C. Miller, 2008, Haemophilia : the official journal of the World Federation of Hemophilia.

Evaluation of a screening tool for bleeding disorders in a US multisite cohort of women with menorrhagia.

Ambarina S. Faiz, J. Heit, P. Kouides, 2011, American journal of obstetrics and gynecology.

Gender, race and diet affect platelet function tests in normal subjects, contributing to a high rate of abnormal results

C. Miller, S. Stein, K. Garrett, 2014, British journal of haematology.

Chapter 130 – Laboratory Diagnosis of Inherited von Willebrand Disease

C. Miller, 2013 .

Laboratory Diagnosis of Inherited von Willebrand Disease

C. Miller, 2009 .

F8 and F9 mutations in US haemophilia patients: correlation with history of inhibitor and race/ethnicity

W. Hooper, C. Miller, Amanda B. Payne, 2012, Haemophilia : the official journal of the World Federation of Hemophilia.

Coagulation Factor Testing

C. Miller, 2019, Transfusion Medicine and Hemostasis.

Chapter 127 – Coagulation Factor Testing

C. Miller, 2013 .

Reproductive choices in hemophilic men and carriers.

M. Hilgartner, C. Miller, L. Aledort, 1987, American journal of medical genetics.

Occurrence rates of inherited bleeding disorders other than haemophilia and von Willebrand disease among people receiving care in specialized treatment centres in the United States

M. Lewandowska, A. Shapiro, C. Miller, 2022, Haemophilia : the official journal of the World Federation of Hemophilia.

Postdelivery head bleeding in hemophilic neonates. Causes and management.

W. Chadduck, C. Miller, C. Miller, 1989, American journal of diseases of children.

Laboratory Diagnosis of Acquired von Willebrand Syndrome

C. Miller, 2013 .

Chapter 124 – Laboratory Diagnosis of Acquired von Willebrand Syndrome

C. Miller, 2009 .